These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 4632509)

  • 21. [Level of free and bound chlorpromazine fractions in the blood and urine during chlorpromazine treatment].
    Nurowska K; Szajbel W; Waszkiewicz E; Welbel L
    Psychiatr Pol; 1970; 4(4):435-42. PubMed ID: 5472581
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
    Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
    Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of chlorpromazine and its metabolites in human plasma and urine by direct spectrodensitometry of thin-layer chromatograms.
    Chan TL; Sakalis G; Gershon S
    Adv Biochem Psychopharmacol; 1974; 9(0):323-33. PubMed ID: 4836209
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    O'Croinin F; Zibin T
    J Psychiatry Neurosci; 1994 May; 19(3):226. PubMed ID: 8031748
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of response to chlorpromazine treatment in schizophrenics.
    Sakurai Y; Nakahara T; Takahashi R
    Psychopharmacologia; 1975 Oct; 44(2):195-203. PubMed ID: 1105634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in symptoms and plasma homovanillic acid with amantadine hydrochloride in chronic schizophrenia.
    Yamada K; Kanba S; Ohnishi K; Ashikari I; Yagi G; Asai M
    Biol Psychiatry; 1997 May; 41(10):1062-4. PubMed ID: 9129786
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug management in chronic schizophrenia.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1982 Jan; 150(1):45-8. PubMed ID: 7054584
    [No Abstract]   [Full Text] [Related]  

  • 28. Test dose response in schizophrenia: chlorpromazine blood and saliva levels.
    May PR; Van Putten T; Jenden DJ; Cho AK
    Arch Gen Psychiatry; 1978 Sep; 35(9):1091-7. PubMed ID: 686971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laterality and voltage in the EEG of psychiatric patients.
    Serafetinides EA
    Dis Nerv Syst; 1972 Sep; 33(9):622-3. PubMed ID: 4649157
    [No Abstract]   [Full Text] [Related]  

  • 30. Assay of 7-hydroxychlorpromazine, and failure to detect more than small quantities, in plasma of responding schizophrenics.
    Curry SH; Evans S
    Psychopharmacol Commun; 1975; 1(5):481-90. PubMed ID: 1241720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does a plasma level of chlorpromazine help?
    Van Putten T; May PR; Jenden DJ
    Psychol Med; 1981 Nov; 11(4):729-34. PubMed ID: 6119719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of chlorpromazine in schizophrenia; a critical review of the literature.
    May PR; Van Putten T
    Arch Gen Psychiatry; 1978 Sep; 35(9):1081-7. PubMed ID: 686970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEG dose-response relationships of chlorpromazine in chronic schizophrenia: the effects on the various rhythms and on alpha blocking.
    Serafetinides EA; Willis D; Clark ML
    Biol Psychiatry; 1972 Jun; 4(3):251-6. PubMed ID: 5041921
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma levels of chlorpromazine and clinical response [proceedings].
    van Putten T; May PR; Jenden DJ
    Psychopharmacol Bull; 1981 Jan; 17(1):113-5. PubMed ID: 7232637
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients.
    Hershey LA; Gift T; Atkins RW; Rivera-Calimlim L
    Psychopharmacology (Berl); 1981; 73(4):355-8. PubMed ID: 6789357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
    Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic therapy for chronic schizophrenia.
    Ayd FJ
    Dis Nerv Syst; 1972 Jan; 33(1):35-9. PubMed ID: 5059687
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term study of molindone hydrochloride in chronic schizophrenics.
    Kellner R; Rada RT; Egelman A; Macaluso B
    Curr Ther Res Clin Exp; 1976 Nov; 20(5):686-94. PubMed ID: 825355
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary excretion of catecholamines and their metabolites in chronic schizophrenics treated with oxypertine and chlorpromazine.
    Kiriike N; Uete T; Motomura K; Enomoto M; Murata K
    Biol Psychiatry; 1984 Mar; 19(3):417-22. PubMed ID: 6144330
    [No Abstract]   [Full Text] [Related]  

  • 40. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
    Platz AR; Klett CJ; Caffey EM
    Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.